From glucose tracking to connected diabetes care

Continuous glucose monitoring is well established in diabetes care. Current innovation is shifting the focus from glucose measurement alone to how continuous monitoring can deliver greater clinical value within diabetes management. Recent developments highlight how new capabilities are extending the role of CGM across the care pathway.

One area of innovation is the integration of additional biomarkers into wearable sensors. New glucose ketone monitoring systems demonstrate how continuous monitoring can extend beyond glycemic control by by providing earlier warning of potential diabetic ketoacidosis through simultaneous glucose and ketone measurements. Combined with digital health platforms that enable data sharing with healthcare professionals, this approach supports more proactive care and data sharing with healthcare providers and caregivers

Another focus is the interpretation of sensor data rather than the measurement itself. Emerging multisensor platforms combine glucose readings with additional physiological parameters such as body temperature, heart activity, and physical activity to distinguish clinically relevant events from measurement artifacts.

One example is the detection of nocturnal compression related false low glucose events, a common limitation of conventional CGM systems. By providing physiological context instead of glucose values alone, this approach could help reduce false alarms, improve confidence in sensor data and may provide automated insulin delivery systems with more contextual information for dosing decisions.

At the same time, automated insulin delivery is becoming more tightly integrated with continuous monitoring. New hybrid closed-loop systems combine wearable glucose sensors, adaptive dosing algorithms, and insulin pumps within a single digital workflow that can be managed directly from a smartphone.

This closer integration simplifies therapy management for people with diabetes while giving healthcare professionals a pathway to start therapy and transition users to the new system when available. Rather than treating monitoring and therapy as separate processes, these systems connect both into a continuous feedback loop.

Recent developments show that continuous glucose monitoring is becoming a broader clinical platform rather than a standalone sensing technology. Additional biomarkers, contextual analytics, and integrated automated insulin delivery strengthen clinical workflows, support remote diabetes management, and provide healthcare professionals with more actionable information throughout the care pathway.

Sources: Kaleido, CRWE WORLD, Medical Device Network